No Data
No Data
Rating information (Target Price change - Part 2) = Santen Pharmaceutical, Arks, ETC.
◎Morgan Stanley MUFG Securities (three-tier: Overweight > Equal Weight > Underweight) Santen Pharmaceutical <4536.T> ―― "Equal Weight" → "Equal Weight", 1750 yen → 1700 yen ◎Okasan Securities (three-tier: Bullish > Neutral > Bearish) Arcs <9948.T> ―― "Neutral" → "Neutral", 2400 yen → 2900 yen ◎Tokai Tokyo Securities (three-tier: Outperform > Neutral > Underperform) Kyudenko <1959.T> ――
Blackwell 3D Engages ARCS Group to Develop AI-Powered App for Instant Home Design
ARCS Logs 11% Lower Attributable Profit for Nine Months to November 2024
List of Conversion Stocks (Part 1) [List of Parabolic Signal Conversion Stocks]
○ List of stocks for Buy transition Market Code Stock Name Closing Price SAR Main Board <1942> Kansai Electric Engineering 2420 2304 <2489> ADWAYS 300282 <2792> Honeys HD 17121611 <3612> World 26052422 <3681> V-cube 194178 <3962> Change HD 13681175 <4544> HU Group 26282502 <9948> Ar...
Stocks that moved the day before part 1: Cube, Sapeet, Fixstars, ETC.
Stock name <code> Closing price on the 9th ⇒ Change from the previous day Round One <4680> 1157 -572 In December 2024, same-store sales increased by 0.1% in Japan and decreased by 1.5% in the USA. Arcs <9948> 2616 +76 Changed dividend policy and revised the Financial Estimates for dividends for the fiscal year ending February 2025 upward. Dawn <2303> 2212 -147 Operating profit for the first half increased by 15.5%. The growth rate slowed from an 82.0% increase in the first quarter. Narumiya <9275> 1311 -55 Operating profit for the cumulative third quarter decreased by 3.7%.
Afternoon session [Active stocks and traded stocks]
*Round One <4680> 1157 - In December 2024, same-store sales increased by 0.1% in Japan and decreased by 1.5% in the USA. *Arcs <9948> 2616 +76 changed its dividend policy and revised the Financial Estimates for dividends for the fiscal year ending February 2025 upwards. *Dawn <2303> 2212 -147 operating profit for the first half increased by 15.5%. The growth rate has slowed from an increase of 82.0% in the first quarter. *Narumiya <9275> 1311 -55 operating profit for the third quarter cumulative decreased by 3.7%, following an increase of 10.9% in the first half.